Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals's Overview
Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a variety of diseases. Kiniksa is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need, primarily in autoinflammatory and autoimmune conditions. Their lead commercial product is ARCALYST® (rilonacept), an IL-1α and IL-1β cytokine trap for the treatment of recurrent pericarditis and other IL-1 mediated inflammatory diseases.
Where is Kiniksa Pharmaceuticals's Headquarters?
HQ Function
Serves as the global headquarters, housing executive leadership, research and development, commercial operations, and administrative functions.
Notable Features:
Located in a prominent biotechnology hub, providing access to a rich ecosystem of talent and research institutions. The facility likely includes modern office spaces and potentially laboratory facilities.
Work Culture:
Characterized by a science-driven, patient-focused environment that encourages innovation, collaboration, and a commitment to addressing unmet medical needs.
HQ Significance:
Strategically positioned in the Greater Boston area, one of the world's leading centers for biopharmaceutical innovation, facilitating partnerships and talent acquisition.
Values Reflected in HQ: The headquarters' location and setup likely reflect Kiniksa's commitment to scientific excellence, innovation, and collaboration within the biotech community.
Location:
Kiniksa Pharmaceuticals maintains a global presence to support its research, development, and commercialization efforts. Its U.S. headquarters in Lexington, MA, is central to its operations. The company also has significant corporate functions managed through its Bermuda entity and R&D/clinical operations support in San Diego, CA, and the United Kingdom. This structure allows Kiniksa to conduct global clinical trials, engage with international regulatory bodies, and prepare for potential global product launches.
Street Address:
100 Hayden Avenue
City:
Lexington
State/Province:
Massachusetts
Country:
USA
Kiniksa Pharmaceuticals's Global Presence
Hamilton, Bermuda
Address: Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda
Facilitates international corporate governance, financial strategy, and global operational oversight.
San Diego, California, USA
Address: Undisclosed specific street address, but operational presence confirmed.
Contributes to Kiniksa's R&D pipeline by engaging in discovery and preclinical development efforts.
London, United Kingdom
Address: Kiniksa Pharmaceuticals (UK), Ltd. (Specific address varies, often registered agent address)
Manages and oversees clinical trials, regulatory interactions, and market access strategies within the UK and Europe.
Buying Intent Signals for Kiniksa Pharmaceuticals
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Kiniksa Pharmaceuticals
As of April 2025, Kiniksa Pharmaceuticals' leadership includes:
Investors of Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Based on publicly available information, there have been no major C-suite executive new hires or departures publicly announced for Kiniksa Pharmaceuticals within the last 12-18 months. The executive team listed appears stable. Mark Ragosa was appointed CFO in January 2023, which is slightly outside the 12-month window but represents the most recent significant C-level change.
Technology (Tech Stack) used by Kiniksa Pharmaceuticals
Discover the tools Kiniksa Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Kiniksa Pharmaceuticals Email Formats and Examples
Kiniksa Pharmaceuticals likely utilizes common corporate email formats. The most probable format is the first initial followed by the last name.
[first_initial][last]@kiniksa.com
Format
jdoe@kiniksa.com
Example
80%
Success rate
News and media
GlobeNewswire • May 9, 2024
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Kiniksa announced its Q1 2024 financial results, highlighting ARCALYST® (rilonacept) net revenue of $90.6 million and reiterated its 2024 ARCALYST net revenue guidance of $360 to $380 million. The company also provided updates on its clinical programs....more
GlobeNewswire • March 7, 2024
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
Kiniksa reported its financial results for Q4 and full-year 2023, with ARCALYST® net revenue of $79.5 million for Q4 and $233.2 million for the full year. The company also provided updates on its pipeline....more
GlobeNewswire • February 20, 2024
Kiniksa Pharmaceuticals to Present at TD Cowen 44th Annual Health Care Conference
Kiniksa announced its participation and presentation at the TD Cowen 44th Annual Health Care Conference, where it provided a corporate update and discussed its strategic outlook....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Kiniksa Pharmaceuticals, are just a search away.